ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Sectoral/ Thematic · ICICI Prudential Asset Management Company Limited
Among the 946 funds in its category, this one has grown money faster than most. ₹1 lakh invested 5 years ago would be about ₹2 lakh today. Investing ₹10,000 every month for the last 5 years would have put in ₹6.1 lakh and grown it to about ₹9.9 lakh. Be warned: in its worst stretch, ₹1 lakh briefly shrank to about ₹79,420. Expect meaningful ups and downs on the way.
New to fund research? Start with the 5-minute guide. The detailed numbers below back all of this up.ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is a Sectoral/ Thematic fund from ICICI Prudential Asset Management Company Limited. It has a track record of about 8.2 years. As of the latest data it carries an RS rating of 69/99 (its recent momentum versus category peers) and a King Score of 81/100 (a long-term quality composite). The current NAV is ₹46.04 (as of 2026-09-16).
Growth of ₹100 - last 5 years
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund returns: last 1, 3, 5 and 10 years
| Period | This fund | Category average |
|---|---|---|
| 1 month | -2.87% | -3.47% |
| 3 months | 2.2% | 2.0% |
| 6 months | 14.05% | 10.56% |
| 1 year | 5.14% | 4.78% |
| 3 years (CAGR) | 21.12% | 13.85% |
| 5 years (CAGR) | 15.42% | 12.48% |
The last 5 years return is 15.42% a year (₹1 lakh → ₹2 lakh), and the last 3 years return is 21.12% - ahead of its category's 13.85% average by 7.3 points. Its trailing one-year return is 5.14%. Trailing returns flatter or disappoint depending on the end date you pick - the year-by-year and rolling-return sections below are a fairer read.
Year-by-year returns
| Year | ICICI Prudential Pharm | Benchmark |
|---|---|---|
| 2019 | +6.2% | -9.3% |
| 2020 | +73.5% | +60.6% |
| 2021 | +19.3% | +10.1% |
| 2022 | -7.6% | -11.4% |
| 2023 | +42.6% | +33.6% |
| 2024 | +49.4% | +39.1% |
| 2025 | +0.0% | -2.9% |
| 2026 | +6.9% | +15.2% |
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund beat its benchmark in 7 of the last 8 calendar years. That is a strong hit-rate - most active funds fail to clear their index this often. Consistency against the benchmark matters more than any single great year.
Calendar-year returns show how bumpy the ride really was - an average hides the good years and the ugly ones.
What a monthly SIP in ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund would have made
A ₹10,000-a-month SIP, using this fund's actual NAV history. SIP returns (XIRR) differ from lumpsum CAGR because your money goes in gradually, averaging your entry price.
| SIP duration | You invested | It became | XIRR |
|---|---|---|---|
| 3 years | ₹370,000 | ₹457,227 | 14.23% |
| 5 years | ₹610,000 | ₹990,565 | 19.44% |
Over 5 years, ₹610,000 invested in monthly instalments would have grown to about ₹990,565 - an XIRR of 19.44%. Figures are pre-tax and assume you stayed invested throughout.
Risk & drawdowns
| Measure | This fund | Category average |
|---|---|---|
| Worst drawdown (lifetime) | -20.58% | -26.37% |
| Worst drawdown (3Y) | -16.2% | -20.9% |
| Volatility (1Y) | 16.14% | 19.02% |
| Sharpe (3Y) | 1.02 | 0.31 |
| Sortino (3Y) | 1.74 | 0.82 |
| Beta (3Y) | 0.92 | 0.91 |
| Alpha (3Y) | 3.13% | 6.12% |
| Up capture | 95.4% | 97.13% |
| Down capture | 87.7% | 81.47% |
| Bull-market return | 29.4% | 30.78% |
| Bear-market return | 0.3% | -23.76% |
Timing matters more than people admit: the best possible 1-year stretch in ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund (starting 2020-03-23) gained 94.3%, while the worst (starting 2021-09-16) lost 12.3%. The worst peak-to-bottom fall ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund has ever put investors through is -20.58% - the real test of whether you'd have stayed invested. In falling markets (Nifty below its 200-day average) it has returned about 0.3% annualised, versus 29.4% in rising markets. It has captured roughly 95.4% of its benchmark's up-moves and 87.7% of its down-moves.
How ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund behaves when markets fall
When the market is falling (the Nifty below its 200-day average), ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund has historically returned about 0.3% annualised, versus roughly 29.4% when the market is rising. Its deepest fall on record is -20.58%. Right now it sits about 3.88% below its all-time high (last hit 2026-08-12). The real question isn't the average year - it's whether you could hold on through the worst one.
How ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund ranks in its category
Percentile versus its ~946 category peers - 100th is best-in-class, 50th is average. This is the fairest apples-to-apples read.
Consistency (rolling returns)
| Measure | Value |
|---|---|
| Median 3Y rolling CAGR | 25.41% |
| 3Y windows positive | 100.0% |
| Worst 3Y window | 14.94% |
| 3Y windows beating Nifty 500 | 78.5% |
| Median 5Y rolling CAGR | 24.71% |
Instead of one lucky start date, rolling returns test every start date. Across all 3-year windows in its history, ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund returned a median of 25.41% a year, and 100.0% of those windows were positive.
What ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund holds
Its latest monthly portfolio disclosure. This is what your money actually owns.
Top holdings
Sector allocation
The top 10 holdings make up 60.7% of the portfolio, across 37 stocks. A higher concentration means the fund's fortunes ride on fewer names.
Portfolio overlap with similar funds
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund shares ICICI Prudential Innovation Fund (14%), HDFC Transportation and Logistics Fund (0%), ICICI Prudential Transportation And Logistics Fund (0%) of its portfolio with these category peers (overlap = the slice of the two portfolios invested in the same stocks). The lower the overlap, the more genuinely different the portfolios are.
Who manages ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - and how good are they?
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is managed by Dharmesh Kakkad and Sharmila D’mello. Below is each manager's complete track record - every fund they currently run, judged on the same numbers as everything else on this page - so you can see whether this fund is in strong hands or is the outlier in a weak book.
Dharmesh Kakkad's full record
Dharmesh Kakkad currently runs 7 funds, across Equity Savings, FoF Domestic, Sectoral/ Thematic, Value Fund, with about ₹120,003 Cr under management. The book's average King Score is 58.9/100. This fund is the highest-scored fund they run (King 81/100).
Tap any column heading to sort.
| # | Fund | RS | King | 3M | 6M | 1Y | 3Y CAGR | 5Y CAGR | 10Y CAGR | Sharpe | Roll 3Y | Worst fall |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund (this page) | 69 | 81 | 2.2% | 14.1% | 5.1% | 21.1% | 15.4% | n/a | 1.02 | 25.4% | -20.6% |
| 2 | ICICI Prudential Value Fund (erstwhile Value Discovery Fund) | 16 | 73 | -3.1% | -2.6% | -6.1% | 10.7% | 13.8% | 14.2% | 0.35 | 20.5% | -36.7% |
| 3 | ICICI Prudential Equity Savings Fund | 64 | 58 | 1.1% | 1.8% | 2.5% | 6.7% | 7.4% | 7.9% | 0.07 | 8.8% | -19.2% |
| 4 | ICICI Prudential Dynamic Asset Allocation Active FOF | 24 | 57 | -0.3% | 3.7% | 1.7% | 10.2% | 10.7% | 12.1% | 0.55 | 13.8% | -26.4% |
| 5 | ICICI Prudential Diversified Equity All Cap Omni FOF | 29 | 51 | 0.1% | 6.1% | -0.0% | 13.6% | 14.1% | n/a | 0.53 | 23.8% | -31.4% |
| 6 | ICICI Prudential Aggressive Hybrid Active FOF | 32 | 49 | 1.1% | 6.0% | -1.1% | 12.7% | 13.1% | 15.2% | 0.57 | 18.7% | -35.7% |
| 7 | ICICI Prudential Multi Sector Passive FOF | 29 | 43 | -0.7% | 5.4% | 2.1% | 11.3% | 11.0% | 12.5% | 0.39 | 13.9% | -34.9% |
Sharmila D’mello's full record
Sharmila D’mello currently runs 21 funds, across Children s Fund, Flexi Cap Fund, FoF Overseas, Mid Cap Fund and more, with about ₹140,783 Cr under management. The book's average King Score is 68.3/100. Their strongest fund by King Score is ICICI Prudential Flexicap Fund (88/100); ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund ranks #5 of 21 in their book.
Tap any column heading to sort.
| # | Fund | RS | King | 3M | 6M | 1Y | 3Y CAGR | 5Y CAGR | 10Y CAGR | Sharpe | Roll 3Y | Worst fall |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ICICI Prudential Flexicap Fund | 83 | 88 | 3.7% | 12.9% | 3.4% | 14.8% | 14.6% | n/a | 0.55 | 20.4% | -19.7% |
| 2 | ICICI Prudential Transportation And Logistics Fund | 78 | 87 | 6.5% | 15.9% | 6.1% | 21.1% | n/a | n/a | 0.78 | 27.8% | -23.6% |
| 3 | ICICI Prudential Innovation Fund | 56 | 87 | 2.3% | 9.5% | 1.1% | 17.8% | n/a | n/a | 0.84 | 22.4% | -16.5% |
| 4 | ICICI Prudential Retirement Fund - Hybrid Conservative | 77 | 84 | 0.9% | 3.1% | 5.3% | 9.6% | 8.6% | n/a | 0.63 | 9.8% | -10.2% |
| 5 | ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund (this page) | 69 | 81 | 2.2% | 14.1% | 5.1% | 21.1% | 15.4% | n/a | 1.02 | 25.4% | -20.6% |
| 6 | ICICI Prudential PSU Equity Fund | 40 | 81 | -1.4% | 0.4% | 6.6% | 19.9% | n/a | n/a | 0.66 | 28.5% | -23.0% |
| 7 | ICICI Prudential Children's Fund | 35 | 81 | -1.5% | 4.4% | -2.6% | 11.7% | 11.4% | 11.4% | 0.38 | 14.1% | -31.1% |
| 8 | ICICI Prudential MidCap Fund | 59 | 80 | -2.2% | 10.4% | 11.9% | 20.1% | 16.7% | 16.8% | 0.74 | 21.0% | -44.0% |
| 9 | ICICI Prudential Retirement Fund - Hybrid Aggressive | 85 | 79 | -0.5% | 7.6% | 6.1% | 16.4% | 14.6% | n/a | 0.69 | 20.7% | -28.7% |
| 10 | ICICI Prudential Multicap Fund | 38 | 72 | -2.1% | 10.7% | 5.0% | 14.4% | 14.1% | 14.4% | 0.56 | 17.7% | -38.9% |
| 11 | ICICI Prudential Infrastructure Fund | 39 | 69 | -2.5% | 7.1% | 1.7% | 16.5% | 20.7% | 17.4% | 0.58 | 18.0% | -46.8% |
| 12 | ICICI Prudential Exports & Services Fund | 50 | 67 | 0.7% | 8.1% | 1.5% | 13.4% | 13.4% | 13.8% | 0.54 | 18.8% | -37.5% |
| 13 | ICICI Prudential India Opportunities Fund | 22 | 66 | -1.9% | 1.3% | -1.1% | 12.9% | 16.9% | n/a | 0.51 | 26.7% | -40.1% |
| 14 | ICICI Prudential Quant Fund | 34 | 65 | -0.1% | 4.0% | -2.2% | 10.5% | 9.9% | n/a | 0.31 | 17.9% | -16.5% |
| 15 | ICICI Prudential Housing Opportunities Fund | 15 | 64 | -3.2% | 2.4% | -2.8% | 9.9% | n/a | n/a | 0.24 | 18.7% | -16.7% |
| 16 | ICICI Prudential Commodities Fund | 32 | 60 | -5.2% | 3.9% | 6.8% | 13.4% | 13.5% | n/a | 0.34 | 23.0% | -41.2% |
| 17 | ICICI Prudential MNC Fund | 49 | 56 | -0.7% | 8.1% | 3.4% | 9.5% | 11.2% | n/a | 0.24 | 19.8% | -30.7% |
| 18 | ICICI Prudential ESG Exclusionary Strategy Fund | 20 | 55 | -0.4% | 3.0% | -6.8% | 10.6% | 9.3% | n/a | 0.31 | 18.2% | -19.2% |
| 19 | ICICI Prudential Bharat Consumption Fund | 42 | 50 | 1.5% | 8.2% | -6.2% | 9.1% | 12.4% | n/a | 0.2 | 19.8% | -31.3% |
| 20 | ICICI Prudential Global Stable Equity Fund (FOF) | 63 | 43 | 6.3% | 9.4% | 18.6% | 14.1% | 11.2% | 10.7% | 0.59 | 9.4% | -26.2% |
| 21 | ICICI Prudential Technology Fund | 52 | 20 | 6.1% | 9.7% | -10.0% | 5.0% | 3.0% | 17.5% | -0.08 | 15.7% | -35.1% |
A caveat worth keeping: funds often have co-managers, and results belong to the whole team and process rather than one person. A manager's book tells you about their range and consistency, not a guarantee of skill.
Cost & fund basics
| Detail | Value |
|---|---|
| Expense ratio (Direct) | 0.87% |
| Exit load | ≈1% if redeemed within 1 year (typical) |
| Minimum investment | ₹5000 |
| Fund size (AUM) | ₹6,453 Cr |
| Age | 8.2 years |
| Plan / Option | Direct · Growth |
| Benchmark | NIFTY_PHARMA |
How ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund compares to peers
| Fund | RS | King | 3Y CAGR |
|---|---|---|---|
| HDFC Transportation and Logistics Fund | 82 | 89 | 24.1% |
| ICICI Prudential Transportation And Logistics Fund | 78 | 87 | 21.1% |
| ICICI Prudential Innovation Fund | 56 | 87 | 17.8% |
| LIC MF Healthcare Fund | 91 | 87 | 21.4% |
| Kotak Manufacture in India Fund | 81 | 83 | 19.1% |
| HDFC Defence Fund | 87 | 83 | 36.0% |
Overlap warning: funds in the same category often own many of the same stocks - holding several rarely adds the diversification people expect.
What these numbers mean
RS rating (1-99) ranks a fund's recent momentum against its category - higher is stronger right now. King Score (0-100) is a long-term quality composite (returns, consistency, drawdown, risk-adjusted return) versus peers. Max drawdown is the worst peak-to-bottom fall the fund has ever experienced. Rolling returns test every possible start date, so one lucky (or unlucky) entry point can't distort the picture. Every formula behind this page is public - see how we calculate every number.
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund review: the bottom line
Related
Frequently asked questions
Is ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund a good mutual fund?
That depends on your goals and risk tolerance - this is descriptive research, not advice. On the numbers, ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund scores 81/100 on our King Score and RS 69/99 within its category, has compounded 21.12% a year over three years, and its worst drawdown was -20.58%. Compare those against your needs and the peer table above.
What is the NAV of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund today?
The latest NAV is ₹46.04 (as of 2026-09-16). NAV (net asset value) is the per-unit price of the fund, published every business day by the AMC.
What is the expense ratio of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund?
The Direct-plan expense ratio is 0.87% a year. The Direct plan is cheaper than the Regular plan because it carries no distributor commission - over decades that gap compounds meaningfully.
Who is the fund manager of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund?
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is managed by Dharmesh Kakkad; Sharmila D’mello.
Is ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund safe? How risky is it?
No market-linked fund is 'safe' in the fixed-deposit sense - the honest question is how deep its falls get. Its worst historical drawdown was -20.58% - ₹1 lakh briefly becoming about ₹79,420. As a sectoral & thematic fund, its risk profile is typical of that category. Look at the drawdown, volatility and bear-market figures above and ask whether you could stay invested through the bad stretches.
Is ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund good for SIP?
We can't tell you what to do, but here is what actually happened: a ₹10,000 monthly SIP over the last 5 years grew ₹6.1 lakh into about ₹9.9 lakh (XIRR 19.44%). SIPs average your entry price, which helps most in funds that swing hard - check the crash-behaviour section above to see how it treats investors in bad markets.
What are the SIP returns of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund?
A ₹10,000/month SIP over 5 years would have grown to about ₹990,565 (an XIRR of 19.44%) on ₹610,000 invested, using the fund's actual NAV history. See the SIP table above for other durations.
How does ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund rank among similar funds?
On 3-year returns it sits around the 95th percentile of its category, and its consistency ranks 61th percentile. 100th is best-in-class, 50th is average. See the category-ranking section above.
Is ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund tax-efficient / what about capital gains?
As a sectoral & thematic fund, gains follow the rules for its asset class - equity-oriented funds are taxed differently from debt. All returns on this page are pre-tax; your actual post-tax return depends on your holding period and slab. This is descriptive information, not tax advice.
Direct or Regular plan - which is shown here?
All figures on this page are for the Direct-Growth plan (no distributor commission, lower cost). Returns are pre-tax; capital-gains tax depends on your own holding period and slab.
See ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund live in the MF Terminal
Everything above is a static snapshot. The terminal is where you actually research it:
- Interactive price chart with EMAs & RSI
- The RS line plotted against its benchmark
- Full holdings, sector mix & portfolio overlap
- Point-in-time backtester & portfolio doctor
- Compare it side-by-side with any peer
- Screen 1,600+ funds on the same metrics
Data: AMFI NAV history, NSE indices, BSE StAR and monthly disclosures. All figures are pre-tax. Descriptive research and education only - nothing here is investment advice or a recommendation to buy, sell or hold any fund. Past performance does not guarantee future returns.